Section Arrow
SPRB.NASDAQ
- Spruce Biosciences Inc
Quotes are at least 15-min delayed:2026/03/02 12:47 EST
Regular Hours
Last
 54.23
-0.81 (-1.47%)
Day High 
55 
Prev. Close
55.04 
1-M High
86.945 
Volume 
15.88K 
Bid
52.6
Ask
55.86
Day Low
51.78 
Open
53.86 
1-M Low
48.08 
Market Cap 
58.91M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 56.44 
20-SMA 67.71 
50-SMA 75.38 
52-W High 240 
52-W Low 0.057 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-84.32/-23.90
Enterprise Value
59.77M
Balance Sheet
Book Value Per Share
5.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
4.91M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
IBRXImmunityBio10.7+0.9+9.18%-- 
OCULOcular Therapeutix10.525+1.58+17.66%-- 
QNCXQuince Therapeutics0.1053-0.0148-12.32%-- 
QUREuniQure NV9.96-5.62-36.07%-- 
NTLAIntellia Therapeutics14.9725+1.2025+8.73%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.